Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Edward Schuchman
Icahn School of Medicine at Mount Sinai, Department: Genetics
Should you be removed from our database? Contact us at [email protected]. Read more below.
Genzyme Corporation
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Dr. Schuchman, the Principal Investigator, is a consultant to Genzyme Corporation. Genzyme Corporation has licensed patents for the development of Enzyme Replacement Therapy (ERT) for the treatment of Niemann-Pick Disease.
Acid Sphingomyelinase and Niemann-Pick Disease
ASM deficiency (Types A and B Niemann-Pick disease; NPD) is a debilitating and often fatal lysosomal storage disease. Research in this grant application will use mouse models of NPD to evaluate two novel treatment approaches, and to gain a further understanding of the pathogenic mechanisms leading to liver disease and enzyme replacement therapy-related liver toxicity. Clinically important questions will be addressed, and the results should have high translational value for this and other lysosomal storage diseases.
Filed on July 31, 2014.
Tell us what you know about Edward Schuchman's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Edward Schuchman filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Edward Schuchman | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Plexcera Therapeutics | $200,000 - $249,999 |
| Edward Schuchman | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Plexcera Therapeutics | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.